Axishil contains Axitinib, which is a type of anti-cancer medicine. It is a targeted therapy used mainly for kidney cancer. Unlike normal chemotherapy, it blocks specific proteins that help cancer cells grow new blood vessels.
Mechanism
-
Cancer cells need blood supply to grow.
-
Axitinib blocks a group of proteins called VEGF receptors (Vascular Endothelial Growth Factor Receptors).
-
By blocking these receptors, Axitinib stops the formation of new blood vessels (angiogenesis) that feed the tumor.
-
This slows down or stops the growth of cancer cells.
Uses
-
Mainly used to treat advanced kidney cancer (renal cell carcinoma).
-
Sometimes used when other treatments did not work.
Adverse Effects (Side effects)
Common side effects include:
-
High blood pressure
-
Tiredness and weakness
-
Diarrhea or stomach upset
-
Loss of appetite and weight loss
-
Mouth sores
-
Nausea and vomiting
-
Hand-foot syndrome (redness, pain, or peeling skin on palms and soles)
-
-




